{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2012 sorted by posted_date descending", "rows": [["FDA-2011-N-0899-0003", "FDA", "FDA-2011-N-0899", "Finding of no Significant Impact for Genetically Engineered Atlantic Salmon (AquAdvantage Salmon)", "Notice", "Availability of Document", "2012-12-27T05:00:00Z", 2012, 12, "2012-12-27T05:00:00Z", "2013-04-27T03:59:59Z", "2014-11-14T03:06:12Z", null, 0, 0, "090000648119d263"], ["FDA-2011-N-0899-0001", "FDA", "FDA-2011-N-0899", "Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning a Genetically Engineered Atlantic Salmon; Availability", "Notice", "General Notice", "2012-12-26T05:00:00Z", 2012, 12, "2012-12-26T05:00:00Z", "2013-02-15T04:59:59Z", "2014-08-21T13:21:56Z", "2012-31118", 0, 0, "090000648119a623"], ["FDA-2012-N-0176-0004", "FDA", "FDA-2012-N-0176", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study; Examination of Corrective Direct-to-Consumer Television Advertising", "Notice", "General Notice", "2012-12-26T05:00:00Z", 2012, 12, "2012-12-26T05:00:00Z", null, "2012-12-28T16:20:17Z", "2012-31028", 0, 0, "090000648119a713"], ["FDA-2012-N-0001-0153", "FDA", "FDA-2012-N-0001", "Public Workshops: Minimal Residual Disease", "Notice", "Meeting", "2012-12-26T05:00:00Z", 2012, 12, "2012-12-26T05:00:00Z", null, "2012-12-26T16:07:03Z", "2012-31043", 0, 0, "090000648119a540"], ["FDA-2010-D-0643-0051", "FDA", "FDA-2010-D-0643", "Draft Guidances for Industry; Availability, etc.: Electronic Source Data in Clinical Investigations; Correction", "Notice", "Correction", "2012-12-26T05:00:00Z", 2012, 12, "2012-12-26T05:00:00Z", null, "2012-12-26T15:59:59Z", "2012-31027", 0, 0, "0900006481199d80"], ["FDA-2012-N-0001-0154", "FDA", "FDA-2012-N-0001", "Public Workshops on Minimal Residual Disease", "Notice", "Meeting", "2012-12-26T05:00:00Z", 2012, 12, "2012-12-26T05:00:00Z", null, "2012-12-26T16:13:42Z", "2012-31044", 0, 0, "090000648119a75b"], ["FDA-2011-N-0899-0002", "FDA", "FDA-2011-N-0899", "Draft Environmental Assessment for Genetically Engineered Atlantic Salmon (AquAdvantage Salmon)", "Notice", "Availability of Environmental Assessment", "2012-12-26T05:00:00Z", 2012, 12, "2012-12-26T05:00:00Z", "2013-04-27T03:59:59Z", "2015-04-11T02:05:38Z", null, 0, 0, "090000648119a936"], ["FDA-2012-N-1181-0001", "FDA", "FDA-2012-N-1181", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Medicated Feed Mill License Application; Extension", "Notice", "Notice of Extension", "2012-12-21T05:00:00Z", 2012, 12, "2012-12-21T05:00:00Z", "2013-02-20T04:59:59Z", "2013-01-09T03:07:26Z", "2012-30738", 0, 0, "09000064811954b9"], ["FDA-2002-N-0106-0003", "FDA", "FDA-2002-N-0106", "Denial of Hearing on Application for Special Termination of Debarment: Baldev Raj Bhutani", "Notice", "Notice of Final Rule", "2012-12-21T05:00:00Z", 2012, 12, null, null, "2012-12-21T14:50:12Z", "2012-30709", 0, 0, "09000064811954bc"], ["FDA-2010-D-0482-0033", "FDA", "FDA-2010-D-0482", "Guidances for Industry and Investigators; on Safety Reporting Requirements for Investigational New Drug Applications and Bioavailability/ Bioequivalence Studies, and a Small Entity Compliance Guide; Availability", "Notice", "Notice of Availability", "2012-12-20T05:00:00Z", 2012, 12, "2012-12-20T05:00:00Z", null, "2019-08-22T20:02:45Z", "2012-30651", 0, 0, "0900006481193abb"], ["FDA-2012-N-0548-0086", "FDA", "FDA-2012-N-0548", "Drug Safety and Risk Management Advisory Committee Notice of Meeting", "Notice", "Meeting", "2012-12-19T05:00:00Z", 2012, 12, "2012-12-19T05:00:00Z", "2013-02-02T04:59:59Z", "2013-05-24T01:03:08Z", "2012-30517", 0, 0, "09000064811924c9"], ["FDA-1977-N-0018-0091", "FDA", "FDA-1977-N-0018", "Drug Products for the Treatment and/or Prevention of Nocturnal Leg Muscle Cramps for Over-the-Counter Human Use; Final Rule", "Notice", "Notice of Final Rule", "2012-12-19T05:00:00Z", 2012, 12, "2012-12-19T05:00:00Z", null, "2018-12-26T13:27:13Z", "94-20449", 0, 0, "09000064805d9854"], ["FDA-2012-N-0976-0002", "FDA", "FDA-2012-N-0976", "Agency Information Collection Activities Proposals, Submissions, and Approvals: Emergency Use Authorization of Medical Products", "Notice", "30 Day Proposed Information Collection", "2012-12-19T05:00:00Z", 2012, 12, null, null, "2016-03-04T13:00:50Z", "2012-30513", 0, 0, "0900006481192371"], ["FDA-2012-N-1202-0001", "FDA", "FDA-2012-N-1202", "Comprehensive Assessment of the Process for the Review of Device Submissions; Request for Comments", "Notice", "General Notice", "2012-12-19T05:00:00Z", 2012, 12, "2012-12-19T05:00:00Z", "2013-02-05T04:59:59Z", "2013-02-05T03:01:42Z", "2012-30511", 0, 0, "0900006481192403"], ["FDA-2012-D-1168-0001", "FDA", "FDA-2012-D-1168", "Draft Guidances for Industry Providing Submissions in Electronic Format- Summary Level Clinical Site Data for Center for Drug Evaluation and Research's Inspection Planning; Availability", "Notice", "Notice of Availability", "2012-12-19T05:00:00Z", 2012, 12, "2012-12-19T05:00:00Z", "2013-02-20T04:59:59Z", "2013-02-20T03:08:53Z", "2012-30510", 0, 0, "09000064811922f2"], ["FDA-1999-D-4090-0001", "FDA", "FDA-1999-D-4090", "Medical Devices; Guidance Document for Premarket Notification Submissions for the Nitric Oxide Delivery Apparatus, Nitric Oxide Analyzer, and Nitrogen Dioxide Analyzer; Availability", "Notice", "Notice of Data Availability", "2012-12-19T05:00:00Z", 2012, 12, "2012-12-19T05:00:00Z", "2000-04-25T03:59:59Z", "2025-07-24T18:56:49Z", "00-1535", 0, 0, "09000064804f5f16"], ["FDA-2012-N-1172-0001", "FDA", "FDA-2012-N-1172", "Impact of Approved Drug Labeling on Chronic Opioid Therapy: Public Hearings Request for Comments", "Notice", "Hearings", "2012-12-19T05:00:00Z", 2012, 12, "2012-12-19T05:00:00Z", "2013-04-09T03:59:59Z", "2013-04-17T01:04:39Z", "2012-30516", 0, 0, "090000648119224c"], ["FDA-2012-D-1197-0001", "FDA", "FDA-2012-D-1197", "Draft Guidance for Industry on Certification of Designated Medical Gases; Availability", "Notice", "Notice of Availability", "2012-12-18T05:00:00Z", 2012, 12, "2012-12-18T05:00:00Z", "2013-02-20T04:59:59Z", "2013-02-09T03:01:18Z", "2012-30382", 0, 0, "0900006481190823"], ["FDA-2012-D-1145-0001", "FDA", "FDA-2012-D-1145", "Draft Guidances for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products; Availability", "Notice", "Notice of Availability", "2012-12-17T05:00:00Z", 2012, 12, "2012-12-17T05:00:00Z", "2013-02-16T04:59:59Z", "2013-02-15T03:02:38Z", "2012-30274", 0, 0, "090000648118f64f"], ["FDA-2012-D-1003-0001", "FDA", "FDA-2012-D-1003", "Small Entity Compliance Guide: What You Need to Know About Registration of Food Facilities; Availability", "Notice", "Notice of Availability", "2012-12-17T05:00:00Z", 2012, 12, "2012-12-17T05:00:00Z", null, "2012-12-17T16:14:51Z", "2012-30327", 0, 0, "090000648118f8e1"], ["FDA-2012-N-1167-0001", "FDA", "FDA-2012-N-1167", "Proposals to Withdraw Approvals of New Animal Drug Applications: Ag-Mark, Inc., et al.; Opportunity for Hearing", "Notice", "General Notice", "2012-12-17T05:00:00Z", 2012, 12, "2012-12-17T05:00:00Z", null, "2012-12-17T16:30:35Z", "2012-30089", 0, 0, "090000648118f699"], ["FDA-2004-D-0298-0006", "FDA", "FDA-2004-D-0298", "Compliance Policy Guide: Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs; Notice to Extend Expiration Date", "Notice", "Notice of Availability", "2012-12-17T05:00:00Z", 2012, 12, "2012-12-17T05:00:00Z", null, "2012-12-17T14:58:49Z", "2012-30297", 0, 0, "090000648118f615"], ["FDA-2007-D-0369-0097", "FDA", "FDA-2007-D-0369", "Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability", "Notice", "Notice of Availability", "2012-12-17T05:00:00Z", 2012, 12, "2012-12-17T05:00:00Z", "2013-02-16T04:59:59Z", "2013-02-16T03:01:24Z", "2012-30308", 0, 0, "090000648118f5a2"], ["FDA-2012-D-1002-0001", "FDA", "FDA-2012-D-1002", "Guidances for Industry: Questions and Answers Regarding Food Facility Registration (Fifth Edition)", "Notice", "Notice of Availability", "2012-12-17T05:00:00Z", 2012, 12, "2012-12-17T05:00:00Z", null, "2012-12-17T15:24:50Z", "2012-30328", 0, 0, "090000648118f692"], ["FDA-2012-N-1203-0001", "FDA", "FDA-2012-N-1203", "Agency Information Collection Activities; Proposed Collection; Comment Request; Information to Accompany Humanitarian Device Exemption Applications and Annual Distribution Number Reporting Requirements", "Notice", "60 Day Proposed Information Collection", "2012-12-17T05:00:00Z", 2012, 12, "2012-12-17T05:00:00Z", "2013-02-16T04:59:59Z", "2016-01-07T12:43:50Z", "2012-30275", 0, 0, "090000648118f53f"], ["FDA-2012-N-0001-0151", "FDA", "FDA-2012-N-0001", "Pulmonary-Allergy Drugs Advisory Committee", "Notice", "Meeting", "2012-12-14T05:00:00Z", 2012, 12, "2012-12-14T05:00:00Z", null, "2012-12-14T14:00:46Z", "2012-30171", 0, 0, "090000648118c473"], ["FDA-2012-N-0711-0001", "FDA", "FDA-2012-N-0711", "Establishments of Dockets: Risk Assessment for Establishing Food Allergen Thresholds; Request for Comments", "Notice", null, "2012-12-14T05:00:00Z", 2012, 12, "2012-12-14T05:00:00Z", "2013-02-13T04:59:59Z", "2013-03-06T03:02:08Z", "2012-30123", 0, 0, "090000648118c624"], ["FDA-2012-N-0001-0150", "FDA", "FDA-2012-N-0001", "Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Correction", "Notice", "Correction", "2012-12-13T05:00:00Z", 2012, 12, "2012-12-13T05:00:00Z", null, "2012-12-13T18:54:38Z", "2012-30024", 0, 0, "090000648118b131"], ["FDA-2012-D-1005-0001", "FDA", "FDA-2012-D-1005", "Draft Guidances for Industry on Safety Considerations for Product Design to Minimize Medication Errors; Availability", "Notice", "Notice of Availability", "2012-12-13T05:00:00Z", 2012, 12, "2012-12-13T05:00:00Z", "2013-02-12T04:59:59Z", "2013-02-12T03:01:51Z", "2012-30034", 0, 0, "090000648118af95"], ["FDA-2012-D-1161-0001", "FDA", "FDA-2012-D-1161", "Draft Guidances for Industry and Food and Drug Administration Staff; Design Considerations for Devices Intended for Home Use; Availability", "Notice", "Notice of Availability", "2012-12-13T05:00:00Z", 2012, 12, "2012-12-13T05:00:00Z", "2013-03-14T03:59:59Z", "2013-03-23T02:01:36Z", "2012-30033", 0, 0, "090000648118af5f"], ["FDA-2012-D-0429-0006", "FDA", "FDA-2012-D-0429", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance on Meetings With Industry and Investigators on the Research and Development of Tobacco Products", "Notice", "30 Day Proposed Information Collection", "2012-12-13T05:00:00Z", 2012, 12, "2012-12-13T05:00:00Z", "2013-01-15T04:59:59Z", "2015-09-08T13:34:31Z", "2012-30057", 0, 0, "090000648118b0e3"], ["FDA-2011-N-0568-0004", "FDA", "FDA-2011-N-0568", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study; Disease Information in Branded Promotional Material", "Notice", "Notice of Approval", "2012-12-12T05:00:00Z", 2012, 12, "2012-12-12T05:00:00Z", null, "2012-12-12T14:11:15Z", "2012-29931", 0, 0, "090000648118881d"], ["FDA-2012-D-0530-0019", "FDA", "FDA-2012-D-0530", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance on Medical Devices; Pre-Submission Program and Meetings with FDA Staff", "Notice", "30 Day Proposed Information Collection", "2012-12-11T05:00:00Z", 2012, 12, "2012-12-11T05:00:00Z", "2013-01-11T04:59:59Z", "2015-11-12T13:04:02Z", "2012-29788", 0, 0, "090000648118589b"], ["FDA-2010-N-0304-0001", "FDA", "FDA-2010-N-0304", "Debarment Orders: Susan F. Knott; Denial of Hearing", "Notice", "Notice of Denial", "2012-12-11T05:00:00Z", 2012, 12, "2012-12-11T05:00:00Z", null, "2012-12-11T14:56:16Z", "2012-29782", 0, 0, "0900006481185ab3"], ["FDA-2012-N-0001-0149", "FDA", "FDA-2012-N-0001", "Cellular, Tissue, and Gene Therapies Advisory Committee Meeting", "Notice", "Meeting", "2012-12-10T05:00:00Z", 2012, 12, "2012-12-10T05:00:00Z", null, "2012-12-10T14:45:28Z", "2012-29706", 0, 0, "090000648118457e"], ["FDA-2012-N-0001-0148", "FDA", "FDA-2012-N-0001", "Endocrinologic and Metabolic Drugs Advisory Committee Meeting", "Notice", "Meeting", "2012-12-10T05:00:00Z", 2012, 12, "2012-12-10T05:00:00Z", null, "2012-12-10T14:41:31Z", "2012-29650", 0, 0, "0900006481184647"], ["FDA-2012-N-0001-0147", "FDA", "FDA-2012-N-0001", "Neurological Devices Panel of Medical Devices Advisory Committee Meeting", "Notice", "Meeting", "2012-12-07T05:00:00Z", 2012, 12, "2012-12-07T05:00:00Z", null, "2012-12-07T16:25:14Z", "2012-29538", 0, 0, "09000064811824e2"], ["FDA-2012-N-0001-0146", "FDA", "FDA-2012-N-0001", "Requests for Nominations: Nonvoting Industry Representatives on Public Advisory Panels", "Notice", "General Notice", "2012-12-07T05:00:00Z", 2012, 12, "2012-12-07T05:00:00Z", null, "2012-12-07T16:19:35Z", "2012-29574", 0, 0, "090000648118242a"], ["FDA-2012-D-1086-0001", "FDA", "FDA-2012-D-1086", "Compliance Guidancesfor Small Business Entities; Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use; Availability", "Notice", "Notice of Availability", "2012-12-06T05:00:00Z", 2012, 12, "2012-12-06T05:00:00Z", null, "2012-12-06T17:34:56Z", "2012-29462", 0, 0, "0900006481180cf4"], ["FDA-2012-D-1135-0001", "FDA", "FDA-2012-D-1135", "Guidances for Industry on Limiting Use of Certain Phthalates as Excipients in Center for Drug Evaluation and Research-Regulated Products; Availability", "Notice", "Notice of Availability", "2012-12-06T05:00:00Z", 2012, 12, "2012-12-06T05:00:00Z", null, "2012-12-06T17:25:38Z", "2012-29461", 0, 0, "0900006481180e50"], ["FDA-2012-N-0813-0002", "FDA", "FDA-2012-N-0813", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Applications for Approval to Market New Drug; Revision of Postmarketing Reporting Requirements; Discontinuance", "Notice", "General Notice", "2012-12-05T05:00:00Z", 2012, 12, "2012-12-05T05:00:00Z", "2013-01-05T04:59:59Z", "2012-12-05T14:50:06Z", "2012-29327", 0, 0, "090000648117f7fe"], ["FDA-2012-N-0273-0006", "FDA", "FDA-2012-N-0273", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study of Graphic Cigarette Warning Labels", "Notice", "General Notice", "2012-12-05T05:00:00Z", 2012, 12, "2012-12-05T05:00:00Z", "2013-01-05T04:59:59Z", "2013-01-04T03:02:33Z", "2012-29321", 0, 0, "090000648117f804"], ["FDA-2011-N-0655-0007", "FDA", "FDA-2011-N-0655", "Animal Generic Drug User Fee Act Public Meeting", "Notice", "Meeting", "2012-12-05T05:00:00Z", 2012, 12, "2012-12-05T05:00:00Z", "2013-01-05T04:59:59Z", "2013-01-05T03:04:18Z", "2012-29499", 0, 0, "090000648117eb49"], ["FDA-2011-N-0656-0009", "FDA", "FDA-2011-N-0656", "Animal Drug User Fee Act Public Meeting", "Notice", "Meeting", "2012-12-05T05:00:00Z", 2012, 12, "2012-12-05T05:00:00Z", "2013-01-05T04:59:59Z", "2013-01-05T03:04:25Z", "2012-29498", 0, 0, "090000648117f67f"], ["FDA-2012-N-1040-0002", "FDA", "FDA-2012-N-1040", "Antiseptic Patient Preoperative Skin Preparation Products; Public Hearing; Correction", "Notice", "Correction", "2012-12-04T05:00:00Z", 2012, 12, "2012-12-04T05:00:00Z", null, "2012-12-05T21:36:18Z", "2012-29166", 0, 0, "090000648117e58b"], ["FDA-2012-D-0081-0008", "FDA", "FDA-2012-D-0081", "Guidance on Investigational New Drug Applications for Positron Emission Tomography Drugs", "Notice", "Notice of Availability", "2012-12-04T05:00:00Z", 2012, 12, "2012-12-04T05:00:00Z", null, "2012-12-04T16:52:03Z", "2012-29163", 0, 0, "090000648117e397"], ["FDA-2012-D-0080-0004", "FDA", "FDA-2012-D-0080", "Guidance on Oversight of Positron Emission Tomography Drug Products - Questions and Answers", "Notice", "Notice of Availability", "2012-12-04T05:00:00Z", 2012, 12, "2012-12-04T05:00:00Z", null, "2012-12-04T16:38:40Z", "2012-29157", 0, 0, "090000648117e3df"], ["FDA-2012-N-0001-0145", "FDA", "FDA-2012-N-0001", "Requests for Nominations: Nonvoting Industry Representatives on the Device Good Manufacturing Practice Advisory Committee", "Notice", "General Notice", "2012-12-04T05:00:00Z", 2012, 12, "2012-12-04T05:00:00Z", null, "2012-12-04T16:34:39Z", "2012-29165", 0, 0, "090000648117e51c"], ["FDA-2010-N-0307-0004", "FDA", "FDA-2010-N-0307", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Antiparasitic Drug and Resistance Survey", "Notice", "General Notice", "2012-12-03T05:00:00Z", 2012, 12, "2012-12-03T05:00:00Z", "2013-02-02T04:59:59Z", "2013-01-29T03:01:03Z", "2012-29094", 0, 0, "090000648117c781"], ["FDA-2012-N-0477-0004", "FDA", "FDA-2012-N-0477", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Investigational Device Exemptions Reports and Records", "Notice", "30 Day Proposed Information Collection", "2012-12-03T05:00:00Z", 2012, 12, "2012-12-03T05:00:00Z", "2013-01-03T04:59:59Z", "2015-10-19T14:18:07Z", "2012-29095", 0, 0, "090000648117c85c"], ["FDA-2012-D-1038-0001", "FDA", "FDA-2012-D-1038", "Draft Guidance for Industry; Availability: Preclinical Assessment of Investigational Cellular and Gene Therapy Products", "Notice", "Notice of Availability", "2012-11-29T05:00:00Z", 2012, 11, "2012-11-29T05:00:00Z", "2012-02-28T04:59:59Z", "2012-11-29T14:11:27Z", "2012-28882", 0, 0, "0900006481177429"], ["FDA-2010-N-0099-0010", "FDA", "FDA-2010-N-0099", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Revision of Requirements for Constituent Materials", "Notice", "General Notice", "2012-11-29T05:00:00Z", 2012, 11, "2012-11-29T05:00:00Z", "2013-01-29T04:59:59Z", "2012-11-29T14:03:07Z", "2012-28907", 0, 0, "09000064811773af"], ["FDA-2012-N-0001-0144", "FDA", "FDA-2012-N-0001", "Orthopaedic and Rehabilitation Devices Panel of Medical Devices Advisory Committee Meeting", "Notice", "Meeting", "2012-11-29T05:00:00Z", 2012, 11, "2012-11-29T05:00:00Z", null, "2012-11-29T13:58:43Z", "2012-28855", 0, 0, "09000064811773aa"], ["FDA-2012-N-0386-0006", "FDA", "FDA-2012-N-0386", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments, etc.", "Notice", "Notice of Approval", "2012-11-28T05:00:00Z", 2012, 11, "2012-11-28T05:00:00Z", null, "2022-01-10T21:26:05Z", "2012-28774", 0, 0, "090000648117620b"], ["FDA-2010-D-0276-0005", "FDA", "FDA-2010-D-0276", "Guidances for Industry: Enforcement Policy Concerning Rotational Warning Plans for Smokeless Tobacco Products; Withdrawal", "Notice", "Withdrawal", "2012-11-28T05:00:00Z", 2012, 11, "2012-11-28T05:00:00Z", null, "2012-11-28T15:38:36Z", "2012-28809", 0, 0, "0900006481176269"], ["FDA-2012-N-1154-0001", "FDA", "FDA-2012-N-1154", "Framework for Pharmacy Compounding; State and Federal Roles Meeting", "Notice", "Meeting", "2012-11-28T05:00:00Z", 2012, 11, "2012-11-28T05:00:00Z", "2013-01-19T04:59:59Z", "2013-02-02T03:02:14Z", "2012-28786", 0, 0, "09000064811762e8"], ["FDA-2012-N-1134-0001", "FDA", "FDA-2012-N-1134", "Enforcement Action Dates: Sodium Nitrite Injection and Sodium Thiosulfate Injection Drug Products Labeled for Treatment of Cyanide Poisoning", "Notice", "General Notice", "2012-11-28T05:00:00Z", 2012, 11, "2012-11-28T05:00:00Z", null, "2012-11-28T15:46:40Z", "2012-28773", 0, 0, "09000064811762a3"], ["FDA-2012-N-1021-0001", "FDA", "FDA-2012-N-1021", "Medical Device User Fee and Modernization Act: Web Site Location of Fiscal Year 2013 Proposed Guidance Development", "Notice", "Notice of Intent", "2012-11-26T05:00:00Z", 2012, 11, "2012-11-26T05:00:00Z", null, "2024-11-12T05:09:01Z", "2012-28539", 1, 0, "0900006481173246"], ["FDA-2012-N-0001-0143", "FDA", "FDA-2012-N-0001", "Risk Communication Advisory Committee Meeting", "Notice", "Meeting", "2012-11-26T05:00:00Z", 2012, 11, "2012-11-26T05:00:00Z", null, "2012-11-26T14:57:34Z", "2012-28462", 0, 0, "09000064811730ba"], ["FDA-2011-D-0464-0045", "FDA", "FDA-2011-D-0464", "Guidances for Industry and Staff: Content of Investigational Device Exemption and Premarket Approval Applications for Artificial Pancreas Device Systems", "Notice", "Notice of Data Availability", "2012-11-23T05:00:00Z", 2012, 11, "2012-11-23T05:00:00Z", null, "2024-11-12T05:10:22Z", "2012-28339", 1, 0, "09000064811718ac"], ["FDA-2012-N-1090-0001", "FDA", "FDA-2012-N-1090", "Docket Establishment for Provisions of the Food and Drug Administration Safety and Innovation Act Related to Medical Gases", "Notice", "General Notice", "2012-11-23T05:00:00Z", 2012, 11, "2012-11-23T05:00:00Z", "2013-11-26T04:59:59Z", "2013-11-26T02:01:55Z", "2012-28431", 0, 0, "09000064811718ee"], ["FDA-2012-D-1120-0001", "FDA", "FDA-2012-D-1120", "Draft Guidance for Industry on Vaginal Microbicides: Development for the Prevention of Human Immunodeficiency Virus Infection; Availability", "Notice", "Notice of Availability", "2012-11-23T05:00:00Z", 2012, 11, "2012-11-23T05:00:00Z", "2013-02-22T04:59:59Z", "2013-02-22T03:03:44Z", "2012-28430", 0, 0, "09000064811718a5"], ["FDA-2012-N-1040-0001", "FDA", "FDA-2012-N-1040", "Antiseptic Patient Preoperative Skin Preparation Products Public Hearing Request for Comments", "Notice", "General Notice", "2012-11-21T05:00:00Z", 2012, 11, "2012-11-21T05:00:00Z", "2013-02-13T04:59:59Z", "2013-02-13T03:02:47Z", "2012-28357", 0, 0, "090000648116fd16"], ["FDA-2011-D-0436-0026", "FDA", "FDA-2011-D-0436", "International Conference on Harmonisation; Guidance Availability: Q11 Development and Manufacture of Drug Substances", "Notice", "Notice of Availability", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", null, "2012-11-20T15:21:44Z", "2012-28142", 0, 0, "090000648116e95a"], ["FDA-2012-D-0847-0001", "FDA", "FDA-2012-D-0847", "Draft Guidance for IRBs, Clinical Investigators, and Sponsors; Availability: IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed", "Notice", "Notice of Availability", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", "2013-01-23T04:59:59Z", "2013-01-25T03:01:05Z", "2012-28149", 0, 0, "090000648116eb29"], ["FDA-2012-N-0001-0141", "FDA", "FDA-2012-N-0001", "Pulmonary-Allergy Drugs Advisory Committee Meeting", "Notice", "Meeting", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", null, "2012-11-20T14:27:36Z", "2012-28205", 0, 0, "090000648116e919"], ["FDA-2012-N-0974-0001", "FDA", "FDA-2012-N-0974", "Requests for Comments: Development of Prioritized Therapeutic Area Data Standards", "Notice", "General Notice", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", "2013-01-23T04:59:59Z", "2013-01-23T03:11:12Z", "2012-28197", 0, 0, "090000648116ead9"], ["FDA-2012-N-0001-0142", "FDA", "FDA-2012-N-0001", "Pulmonary-Allergy Drugs Advisory Committee Meeting", "Notice", "Meeting", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", null, "2012-11-20T14:35:46Z", "2012-28201", 0, 0, "090000648116ebd5"], ["FDA-2010-D-0643-0045", "FDA", "FDA-2010-D-0643", "Draft Guidances for Industry; Availability: Electronic Source Data in Clinical Investigations", "Notice", "Notice of Availability", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", "2013-03-27T03:59:59Z", "2013-03-27T02:02:02Z", "2012-28198", 0, 0, "090000648116e9b5"], ["FDA-2012-N-1131-0001", "FDA", "FDA-2012-N-1131", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: New Animal Drug Applications and Supporting Regulations", "Notice", "General Notice", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", "2013-01-23T04:59:59Z", "2012-11-20T14:44:54Z", "2012-28199", 0, 0, "090000648116eb64"], ["FDA-2011-D-0784-0005", "FDA", "FDA-2011-D-0784", "Guidance for Industry; Availability: Evaluating the Effectiveness of Anticoccidial Drugs in Food-Producing Animals", "Notice", "Notice of Availability", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", null, "2012-11-20T15:37:50Z", "2012-28156", 0, 0, "090000648116e9b3"], ["FDA-2003-D-0033-0004", "FDA", "FDA-2003-D-0033", "Guidance for Industry and Food and Drug Administration Staff: Food and Drug Administration and Industry Actions on Premarket Notification Submissions: Effect on Food and Drug Administration Review Clock and Performance Assessment; Availability see FDA-2003-D_0033-0001", "Notice", "Notice of Availability", "2012-11-20T05:00:00Z", 2012, 11, "2012-11-20T05:00:00Z", null, "2022-10-06T19:14:43Z", null, 0, 0, "090000648116e889"], ["FDA-2012-N-1045-0001", "FDA", "FDA-2012-N-1045", "Medical Devices; Custom Devices; Request for Comments", "Notice", "General Notice", "2012-11-19T05:00:00Z", 2012, 11, "2012-11-19T05:00:00Z", "2013-01-19T04:59:59Z", "2013-01-25T03:01:08Z", "2012-28042", 0, 0, "090000648116c9ae"], ["FDA-2012-N-0001-0140", "FDA", "FDA-2012-N-0001", "Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2012-11-16T05:00:00Z", 2012, 11, "2012-11-16T05:00:00Z", null, "2012-11-16T15:08:09Z", "2012-27934", 0, 0, "0900006481168f6e"], ["FDA-2011-D-0164-0007", "FDA", "FDA-2011-D-0164", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Guidance for Industry on Safety Labeling Changes; Implementation of the Federal Food, Drug, and Cosmetic Act", "Notice", "30 Day Proposed Information Collection", "2012-11-16T05:00:00Z", 2012, 11, "2012-11-16T05:00:00Z", "2012-12-18T04:59:59Z", "2015-08-25T11:02:16Z", "2012-27881", 0, 0, "0900006481169eb1"], ["FDA-2012-N-1037-0001", "FDA", "FDA-2012-N-1037", "Establishing a List of Qualifying Pathogens That Have the Potential To Pose a Serious Threat to Public Health; Public Hearing; Request for Comments", "Notice", "General Notice", "2012-11-16T05:00:00Z", 2012, 11, "2012-11-16T05:00:00Z", "2013-01-26T04:59:59Z", "2013-02-06T19:11:36Z", "2012-27931", 0, 0, "0900006481169eb7"], ["FDA-2011-D-0799-0009", "FDA", "FDA-2011-D-0799", "Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components, Including Source Plasma, to Reduce the Risk of Transmission of Hepatitis B Virus", "Notice", "Notice of Availability", "2012-11-15T05:00:00Z", 2012, 11, "2012-11-15T05:00:00Z", null, "2015-04-03T22:43:21Z", "2012-27783", 0, 0, "0900006481168398"], ["FDA-2012-N-1105-0001", "FDA", "FDA-2012-N-1105", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Voluntary Hazard Analysis and Critical Control Point Manuals for Operators and Regulators of Retail and Food Service Establishments", "Notice", "General Notice", "2012-11-15T05:00:00Z", 2012, 11, "2012-11-15T05:00:00Z", "2013-01-15T04:59:59Z", "2012-11-20T03:01:35Z", "2012-27721", 0, 0, "0900006481168435"], ["FDA-2012-N-1106-0001", "FDA", "FDA-2012-N-1106", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Establishing and Maintaining a List of U.S. Dairy Product Manufacturers/Processors with Interest in Exporting to Chile", "Notice", "General Notice", "2012-11-15T05:00:00Z", 2012, 11, "2012-11-15T05:00:00Z", "2013-01-15T04:59:59Z", "2012-11-16T15:02:23Z", "2012-27723", 0, 0, "09000064811685f3"], ["FDA-2012-N-1108-0001", "FDA", "FDA-2012-N-1108", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Interstate Shellfish Dealer's Certificate", "Notice", "General Notice", "2012-11-15T05:00:00Z", 2012, 11, "2012-11-15T05:00:00Z", "2013-01-15T04:59:59Z", "2013-01-15T03:02:51Z", "2012-27722", 0, 0, "0900006481168396"], ["FDA-1995-N-0031-0006", "FDA", "FDA-1995-N-0031", "Compliance Guidance for Small Business Entities; Availability: Labeling for Bronchodilators; Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use", "Notice", "Notice of Availability", "2012-11-15T05:00:00Z", 2012, 11, "2012-11-15T05:00:00Z", null, "2019-10-23T14:21:32Z", "2012-27724", 0, 0, "09000064811685ad"], ["FDA-2012-N-0911-0001", "FDA", "FDA-2012-N-0911", "Privacy Act; Systems of Records", "Notice", "General Notice", "2012-11-14T05:00:00Z", 2012, 11, "2012-11-14T05:00:00Z", "2013-01-01T04:59:59Z", "2012-11-14T15:05:56Z", "2012-27580", 0, 0, "0900006481167317"], ["FDA-2012-N-1093-0001", "FDA", "FDA-2012-N-1093", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Food Additive Petitions and Investigational Food Additive Exemptions", "Notice", "60 Day Proposed Information Collection", "2012-11-13T05:00:00Z", 2012, 11, "2012-11-13T05:00:00Z", "2013-01-15T04:59:59Z", "2015-10-08T15:14:55Z", "2012-27485", 0, 0, "0900006481165cf8"], ["FDA-2012-D-1057-0001", "FDA", "FDA-2012-D-1057", "Draft Guidance for Industry and Staff; Availability: Highly Multiplexed Microbiological/Medical Countermeasure In Vitro Nucleic Acid Based Diagnostic Devices", "Notice", "Notice of Availability", "2012-11-09T05:00:00Z", 2012, 11, "2012-11-09T05:00:00Z", "2013-02-08T04:59:59Z", "2013-02-09T03:01:18Z", "2012-27340", 0, 0, "0900006481164173"], ["FDA-2012-N-0001-0139", "FDA", "FDA-2012-N-0001", "Anesthetic and Analgesic Drug Products Advisory Committee Meeting", "Notice", "Meeting", "2012-11-09T05:00:00Z", 2012, 11, "2012-11-09T05:00:00Z", null, "2012-11-09T14:56:58Z", "2012-27368", 0, 0, "0900006481163fd8"], ["FDA-2012-D-0848-0001", "FDA", "FDA-2012-D-0848", "Draft Compliance Policy Guide; Availability: Canned Ackee, Frozen Ackee, and Other Ackee Products-Hypoglycin A Toxin", "Notice", "Notice of Availability", "2012-11-08T05:00:00Z", 2012, 11, "2012-11-08T05:00:00Z", "2013-01-08T04:59:59Z", "2020-04-28T15:11:26Z", "2012-27225", 0, 0, "0900006481162986"], ["FDA-2012-N-0001-0138", "FDA", "FDA-2012-N-0001", "Blood Products Advisory Committee Meeting", "Notice", "Meeting", "2012-11-08T05:00:00Z", 2012, 11, "2012-11-08T05:00:00Z", null, "2012-11-08T15:21:39Z", "2012-27323", 0, 0, "0900006481162a70"], ["FDA-2012-N-0001-0137", "FDA", "FDA-2012-N-0001", "Circulatory System Devices Panel of Medical Devices Advisory Committee Notice of Meeting", "Notice", "Meeting", "2012-11-07T05:00:00Z", 2012, 11, "2012-11-07T05:00:00Z", null, "2012-11-24T03:00:49Z", "2012-27068", 0, 0, "09000064811613f0"], ["FDA-2012-N-0001-0136", "FDA", "FDA-2012-N-0001", "Burkholderia; Exploring Current Issues and Identifying Regulatory Science Gaps", "Notice", "Meeting", "2012-11-07T05:00:00Z", 2012, 11, "2012-11-07T05:00:00Z", null, "2012-11-07T14:29:08Z", "2012-27146", 0, 0, "09000064811613ec"], ["FDA-2012-N-1075-0001", "FDA", "FDA-2012-N-1075", "Minimum Clinically Important Difference, Outcome Metric in Orthopaedic Device Science and Regulation Public Workshop", "Notice", "Meeting", "2012-11-07T05:00:00Z", 2012, 11, "2012-11-07T05:00:00Z", null, "2012-11-07T14:50:40Z", "2012-27147", 0, 0, "09000064811614d6"], ["FDA-2007-D-0433-0008", "FDA", "FDA-2007-D-0433", "Draft Guidances for Industry; Availability: Bioequivalence Recommendation for Lenalidomide Capsules", "Notice", "Notice of Availability", "2012-11-06T05:00:00Z", 2012, 11, "2012-11-06T05:00:00Z", "2013-01-08T04:59:59Z", "2013-01-08T03:27:42Z", "2012-27004", 0, 0, "090000648115f3c3"], ["FDA-2012-N-0748-0005", "FDA", "FDA-2012-N-0748", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Drug User Fee Cover Sheet", "Notice", "30 Day Proposed Information Collection", "2012-11-06T05:00:00Z", 2012, 11, "2012-11-06T05:00:00Z", "2012-12-07T04:59:59Z", "2015-06-02T15:42:23Z", "2012-27003", 0, 0, "090000648115f3c7"], ["FDA-2012-N-0001-0135", "FDA", "FDA-2012-N-0001", "Cellular, Tissue and Gene Therapies Advisory Committee Meeting", "Notice", "General Notice", "2012-10-30T04:00:00Z", 2012, 10, "2012-10-30T04:00:00Z", null, "2012-10-31T12:22:12Z", "2012-26635", 0, 0, "09000064811552e6"], ["FDA-2012-N-0559-0003", "FDA", "FDA-2012-N-0559", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Public Health Service Guideline on Infectious Disease Issues in Xenotransplantation", "Notice", "30 Day Proposed Information Collection", "2012-10-29T04:00:00Z", 2012, 10, "2012-10-29T04:00:00Z", "2012-11-29T04:59:59Z", "2015-09-22T11:05:31Z", "2012-26494", 0, 0, "090000648115435f"], ["FDA-2012-N-0547-0005", "FDA", "FDA-2012-N-0547", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Retail and Foodservice Facility Types", "Notice", "General Notice", "2012-10-29T04:00:00Z", 2012, 10, "2012-10-29T04:00:00Z", "2012-11-29T04:59:59Z", "2012-11-23T03:00:47Z", "2012-26472", 0, 0, "09000064811543e6"], ["FDA-2009-F-0303-0004", "FDA", "FDA-2009-F-0303", "Filings of Food Additive Petitions: Ajinomoto Co., Inc.; Amendment", "Notice", "General Notice", "2012-10-26T04:00:00Z", 2012, 10, "2012-10-26T04:00:00Z", "2012-11-27T04:59:59Z", "2012-10-30T02:01:58Z", "2012-26315", 0, 0, "09000064811518f2"], ["FDA-2012-N-0007-0005", "FDA", "FDA-2012-N-0007", "Generic Drug User Fee: Backlog Fee Rate for Fiscal Year 2013", "Notice", "General Notice", "2012-10-25T04:00:00Z", 2012, 10, "2012-10-25T04:00:00Z", null, "2012-10-25T16:40:46Z", "2012-26257", 0, 0, "090000648115020e"], ["FDA-2012-N-0007-0004", "FDA", "FDA-2012-N-0007", "Generic Drug User Fee: Abbreviated New Drug Application, Prior Approval Supplement, and Drug Master File Fee Rates for Fiscal Year 2013", "Notice", "General Notice", "2012-10-25T04:00:00Z", 2012, 10, "2012-10-25T04:00:00Z", null, "2012-10-25T16:36:51Z", "2012-26256", 0, 0, "0900006481150373"], ["FDA-2012-N-0001-0134", "FDA", "FDA-2012-N-0001", "Drug Safety and Risk Management Advisory Committee Meeting", "Notice", "Meeting", "2012-10-24T04:00:00Z", 2012, 10, "2012-10-24T04:00:00Z", null, "2012-10-24T13:35:31Z", "2012-26162", 0, 0, "090000648114e4d3"], ["FDA-2012-D-0585-0016", "FDA", "FDA-2012-D-0585", "Guidance for Industry: Necessity of Use of Food Product Categories in Food Facility Registrations and Updates to Food Product Categories; Availability", "Notice", "Notice of Availability", "2012-10-24T04:00:00Z", 2012, 10, "2012-10-24T04:00:00Z", null, "2012-10-24T13:47:42Z", "2012-26239", 0, 0, "090000648114e449"]], "truncated": false, "filtered_table_rows_count": 720, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2012"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012", "results": [{"value": "FDA", "label": "FDA", "count": 720, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2012", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012", "results": [{"value": "Notice", "label": "Notice", "count": 720, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2012", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012", "results": [{"value": 2012, "label": 2012, "count": 720, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_facet_date=last_modified"}], "next": "2012-10-24T04~3A00~3A00Z,FDA-2012-D-0585-0016", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2012&_next=2012-10-24T04~3A00~3A00Z%2CFDA-2012-D-0585-0016&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 636.8618789711036, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}